Provider Alerts
Looking for specific topics? Search the provider Alerts here:
2025
-
FDA Drug Recall Alert – Ropivacaine Hydrochloride Injection USP, 500 mg/100 mL
-
2025 Income Eligibility Guidelines for the Every Woman Counts (EWC) Program
-
Medi-Cal Pharmacy (Rx) Update – Completion of Pediatric Integration
-
Claims Editing System (CES)- Quarterly Update – April 2025
-
Reminder: DHCS Encounter Requirement – Discharge Hour
-
Reminder: Submit Outstanding Claims and Encounters
-
Department of Health Care Services (DHCS), All Plan Letter (APL) 23-029- Memorandum of Understanding Requirements for Medi-Cal Managed Care Plans and Third-Party Entities
-
Medical Benefit Update – Effective June 9, 2025
-
3rd Annual Black Maternal Health Symposium- San Joaquin County
-
Save the Date: Events in Partnership with Valley Children’s Healthcare – April 2025
-
Medi-Cal In-Person Training Event – April 2025
-
Member Resources for Navigating Medi-Cal and Federal Immigration Changes
-
FDA Drug Recall Alert – Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL
-
Medi-Cal Minor Consent Services
-
Free Virtual Substance Use Webinar – People First: Reducing Stigma through Perspective Taking
-
Department of Managed Health Care (DMHC), Office of Planning Licensing (OPL) All Plan Letter 24-023 and Assembly Bill (AB) 1936 – Maternal Mental Health Screenings
-
Mandatory Annual Trainings – Complete by 06/30/2025
-
Revised 1099-Misc Forms
-
Proper Use of Modifier 59
-
Justice-Involved (JI) Reentry Initiative: Rebranding and Screening Portal Updates
Posted on July 17th, 2015 and last modified on January 22nd, 2025.
top